当前位置:首页 - 行情中心 - 众生药业(002317) - 财务分析

众生药业

(002317)

  

流通市值:164.74亿  总市值:183.84亿
流通股本:7.62亿   总股本:8.50亿

众生药业(002317)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.98亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益424999.63万元,未分配利润109013.94万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产534182.02万元,负债109182.39万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入624,239,320.672,522,737,619.71,888,753,875.61,299,729,912.96
营业总成本514,225,795.982,225,746,035.91,625,683,280.091,094,636,663.42
其他经营收益
营业利润112,190,162.14298,299,493.92288,738,830.68216,556,670.44
利润总额117,692,336.37296,585,833.52287,336,316.04215,745,146.82
净利润98,025,231.34266,704,568.89245,497,657.34184,821,629.29
每股收益
其他综合收益-465,901.91-5,349,740.05-6,583,447.99-5,337,076.39
综合收益总额97,559,329.43261,354,828.84238,914,209.35179,484,552.9
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,430,641,844.353,043,657,559.413,098,722,883.073,121,150,116.38
非流动资产:
非流动资产合计1,911,178,346.692,085,889,813.672,068,632,419.322,034,843,052.88
资产总计5,341,820,191.045,129,547,373.085,167,355,302.395,155,993,169.26
流动负债:
流动负债合计829,584,469.9718,319,427.71830,222,745.35880,853,895.08
非流动负债:
非流动负债合计262,239,384.39261,386,177.8211,294,005.01228,799,120.57
负债合计1,091,823,854.29979,705,605.511,041,516,750.361,109,653,015.65
所有者权益(或股东权益):
归属于母公司股东权益合计4,160,206,822.874,058,166,288.884,029,980,658.023,948,476,094.87
股东权益合计4,249,996,336.754,149,841,767.574,125,838,552.034,046,340,153.61
负债和股东权益合计5,341,820,191.045,129,547,373.085,167,355,302.395,155,993,169.26
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计672,674,121.412,362,757,029.651,679,559,979.541,040,028,993.65
经营活动现金流出小计531,139,427.042,057,552,446.971,524,574,853.81,000,364,730.08
经营活动产生的现金流量净额141,534,694.37305,204,582.68154,985,125.7439,664,263.57
投资活动产生的现金流量:
投资活动现金流入小计133,042,420.551,307,334,963.47786,528,997.83662,322,660.22
投资活动现金流出小计488,410,357.591,261,170,977.1849,678,273.01541,987,535.92
投资活动产生的现金流量净额-355,367,937.0446,163,986.37-63,149,275.18120,335,124.3
筹资活动产生的现金流量:
筹资活动现金流入小计18,791,591398,206,741.24277,734,247.37257,025,568.59
筹资活动现金流出小计50,619,886.951,133,736,011.74801,887,356.93793,271,961.85
筹资活动产生的现金流量净额-31,828,295.95-735,529,270.5-524,153,109.56-536,246,393.26
汇率变动对现金及现金等价物的影响-20,914.64-30,491.28-15,840.3-5,718.22
现金及现金等价物净增加额-245,682,453.26-384,191,192.73-432,333,099.3-376,252,723.61
期末现金及现金等价物余额732,210,916.01977,893,369.27929,751,462.7985,831,838.39
补充资料:
现金及现金等价物的净增加额--384,191,192.73--376,252,723.61
最新报告期:2026-05-12
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
东海证券付婷,杜永宏0.410.470.562026-05-12
东方证券伍云飞0.350.380.432026-05-06
开源证券余汝意,巢舒然0.360.390.432026-04-29
天风证券杨松,刘一伯0.350.420.502026-04-24
TOP↑